Skip to main content

Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: A report including 3 cases

Buy Article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Anaphylaxis during induction of anaesthesia is a dreaded complication with a mortality rate of 3–6%, most frequently associated with the use of muscle relaxants. Current knowledge on this matter is reviewed in relation to the presentation of 3 cases of anaphylaxis and bronchospasm associated with the use of the recently released nondepolarizing muscle relaxant rocuronium. Bronchospasm may be the sole sign of a serious drug reaction, triggered by precipitation of insoluble thiopental crystals when mixed with a muscle relaxant in the intravenous (iv) line. It is recommended that these drugs are administered via different injection ports. The hypotension requires immediate treatment with oxygen, epinephrine and large amounts of iv fluids. Epinephrine infusion may be needed for hours. It is recommended that serum tryptase is measured approximately 2 h after debut of the serious drug reaction. Allergy testing should be performed for all the drugs the patient was exposed to, 4–8 weeks after the incident, and due to cross-reactivity, including all available muscle relaxants. Doctors are urged to inform their patients, and systematically register adverse drug reactions.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Adverse effects: anaphylaxis; allergy testing: skin prick test; serum tryptase; drugs: muscle relaxants; rocuronium

Document Type: Original Article

Affiliations: 1: Department of Anaesthesia, Ullevaal University Hospital, Oslo, 2: Department of Anesthesiology and Intensive Care, Haukeland University Hospital, Bergen, Norway

Publication date: 01 August 2000

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more